Have you ever used a type 2 drug as off-label use for a type 1 patient? Follow the link to share your response.
Read More »Production Assistant, Diabetes In Control
International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #106: Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Part 4
The role of statins in the primary and secondary prevention of CVD has been well established. Patients with NAFLD are believed to have increased cardiovascular risk and are logical candidates for their long-term use. In accordance with their higher cardiovascular risk, the use of statins should be encouraged in patients with NAFLD but their use has remained controversial in such patients, particularly in the setting of elevated liver enzymes. Recent practice guidelines on statin use in patients with NAFLD have clearly established that they are overall safe and that they do not carry a higher risk of liver toxicity.
Read More »A New Diabetes Epidemic: “Nonadherence”
How can health care practitioners play a more prominent role in helping patients to take prescribed medications?
Read More »Can Aggressive Glycemic Control in Adults With Diabetes Be Harmful?
The first study to examine overtreatment and deintensification in a Medicare population with diabetes.
Read More »Potential Effects of Exenatide Once-Weekly on Glycemic Control and CV Risk
Injectable extended-release formulation of exenatide in patients with T2DM at a wide range of heart disease risk appeared not to cause increase in overall risk.
Read More »Cholecalciferol Improves Glycemic Control
Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.
Read More »Metformin Linked to Improved Vascular Health in Children With Type 1 Diabetes
Medication also found to further aids in reducing daily insulin dose.
Read More »New Type 2 Treatment?
Would you be interested in learning about a program that can determine the best individual treatments for patients with type 2, based on what the patient can afford using their insurance? Follow the link to see how your colleagues responded.
Read More »Considering Medication Costs
A 47-year-old patient returns for a follow-up visit. He currently takes metformin 2000 mg daily, but is not achieving his glycemic target of A1C <7 %. His current A1C is 8.0%. You would like to add a second medication to his regimen, however, he voices concern that he is no longer covered by any health insurance and is worried about how to pay for his medications. Taking his concern into consideration, what drug would you add to metformin? A. DPP-4 inhibitor B. Thiazolidine C. Sulfonylurea D. Meglitinide E. SGLT2 Inhibitor F. GLP-1 Agonists Follow the link to see the answer.
Read More »SiDiary
With 'SiDiary iPhone' you are able to keep your diabetes logbook (blood glucose levels, blood pressure, medication, carbohydrates, etc.) without the slightest effort as you are already used to from the pc-version of SiDiary 6.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.